# Combined EGFR/MEK Inhibition Prevents the Emergence of Resistance in <i>EGFR</i> -Mutant Lung Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/combined-egfr-mek-inhibition-prevents-the-emergence-of-resistance-in-i-egfr-i/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Erin M. Tricker,Chunxiao Xu,Sharmeen Uddin,Marzia Capelletti,Dalia Ercan,Atsuko Ogino,Christine A. Pratilas,Neal Rosen,Nathanael S. Gray,Kwok‐Kin Wong,Pasi A. Jänne |
| Citations | 220 |
| DOI | 10.1158/2159-8290.cd-15-0063 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://cancerdiscovery.aacrjournals.org/content/candisc/5/9/960.full.pdf |
| OpenAlex ID | https://openalex.org/W2121993228 |
| PMID | 26036643 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Christine A. Pratilas](https://scholariq.org/researchers/christine-a-pratilas/)

## Paper journal

- [Cancer Discovery](https://scholariq.org/journals/cancer-discovery/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.